Influencer la recherche pharmaceutique: un enjeu pour la connaissance des pathologies. Le cas de l'hypercholestérolémie et des statines

Emmanuelle Bonetti

Revue d'économie industrielle, 2007, vol. n° 120, issue 4, 12-12

Abstract: The aim of this paper is to show that the conception of drugs orientates the disease?s knowledge. We will demonstrate this proposition with regard to the hypercholesterolemia?s story. In the first place, we?ll see that the elaboration of treatments fully participates to the evolution of the pathological mechanism?s knowledge. Indeed, the research regarding hypercholesterolemia progressed with the inventing of drugs to lower cholesterol?s level. In the second place, we?ll take an interest in the treatment?s development. We?ll underline the influence of health authorities and clinicians on firm?s choices and strategies. Nevertheless, firm?s financial?s ends move reseach towards limited ways. Thus, in the case of hypercholesterolemia, clinical research has been focused on the question of the cholesterol?s pathological rate.

Keywords: Sociology; Health; Pharmaceutical Industry; Drugs (search for similar items in EconPapers)
Date: 2007
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=REI_120_0012 (application/pdf)
http://www.cairn.info/revue-d-economie-industrielle-2007-4-page-12.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:reidbu:rei_120_0012

Access Statistics for this article

More articles in Revue d'économie industrielle from De Boeck Université
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().